Search

The drug targets a protein called HER2 found on some salivary gland tumors.

… Thursday, January 23, 2020 Albert Kuchler discussing his treatment results with MSK oncologist Bob Li at a recent clinic visit. Albert Kuchler discusses his excellent treatment results with MSK oncologist Bob Li at a recent clinic visit. MSK oncologist Bob Li Dr. Li is developing new clinical trials

Sergio Giralt, MD, has been appointed Chief of the Adult Bone Marrow Transplantation Service in the Division of Hematologic Oncology in the Department of Medicine at Memorial Sloan Kettering Cancer Center.

… Tuesday, June 1, 2010 Sergio Giralt, MD , has been appointed Chief of the Adult Bone Marrow Transplantation Service in the Division of Hematologic Oncology in the Department of Medicine at Memorial Sloan Kettering Cancer Center. “We’re very pleased to have Dr. Giralt, a recognized leader in the field

A new study shows how evolution and natural selection influence clonal hematopoiesis, an aging-related blood condition that increases the risk of blood cancer and cardiovascular disease.

… Monday, August 30, 2021 Artificial intelligence (AI) and machine learning allow researchers to study databases that otherwise would be too large and complex. In a recent study, Sloan Kettering Institute computational biologist Quaid Morris and collaborators used models to study an aging-related blood

A collaborative team of researchers from Memorial Sloan Kettering has determined the mechanism for a biological process that plays a key role in regulating cellular behavior.

… Tuesday, June 1, 2010 Summary A collaborative team of researchers from Memorial Sloan Kettering has determined the mechanism for a biological process that plays a key role in regulating cellular behavior. A collaborative team of researchers from Memorial Sloan Kettering has determined the mechanism for

The May 20 installment of “MSK Science Spotlight” will feature guest speaker, Katherine High, MD, Professor Emerita, Perelman School of Medicine of the University of Pennsylvania; Co-founder and former President and Head of R&D, Spark Therapeutics.

… Wednesday, May 20, 2020 MSK Science Spotlight The May 20 installment of “ MSK Science Spotlight ” will feature guest speaker, Katherine High, MD, Professor Emerita, Perelman School of Medicine of the University of Pennsylvania; Co-founder and former President and Head of R&D, Spark Therapeutics. Hosted

A team of researchers led by Memorial Sloan Kettering immunologist Alexander Rudensky has gained new understanding about regulatory T cells -- a subtype of immune cells that suppresses the immune system's reactivity.

… Saturday, January 1, 2011 Summary A team of researchers led by Memorial Sloan Kettering immunologist Alexander Rudensky has gained new understanding about regulatory T cells — a subtype of immune cells that suppresses the immune system’s reactivity. A team of researchers led by Memorial Sloan Kettering

Every year, the Gerstner Sloan Kettering Graduate School of Biomedical Sciences recognizes student research with fellowship awards based on academic excellence.

… Tuesday, September 18, 2018 Summary The Gerstner Sloan Kettering Graduate School of Biomedical Sciences has awarded fellowships to two third-year students and six second-year students through the annual Grayer Fellowships, the Olayan Fellowship, the Robert B. Catell Fellowship, the Palestin Fellowship

Meet Nikki Gioia, who treated for Hodgkin lymphoma at MSK and is now an MSK nurse.

… Wednesday, May 9, 2018 Summary This story originally appeared in Bridges, MSK’s newsletter for cancer survivors. Bridges offers a forum in which patients and their families can share stories of inspiration and hope, and of the challenges that can accompany a cancer journey. Learn more about how to receive

Discover how a watch-and-wait approach to treating rectal cancer can help people avoid surgery and preserve normal body functions.

… Tuesday, January 15, 2019 Summary The biggest study of its kind in North America finds a watch-and-wait strategy can have excellent long-term results for some people with rectal cancer. Cancers of the colon and rectum are often grouped together as colorectal cancer because both are part of the large

With the help of machine learning, computational biologists are learning to predict how cancers will evolve.

… Wednesday, June 23, 2021 From amoebas to zebras, all living things evolve. They change over time as pressures from the environment cause individuals with certain traits to become more common in a population while those with other traits become less common. Cancer is no different. Within a growing tumor